528 related articles for article (PubMed ID: 28808860)
21. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
Shao N; Xie C; Shi Y; Ye R; Long J; Shi H; Shan Z; Thompson AM; Lin Y
Cancer Manag Res; 2019; 11():1433-1442. PubMed ID: 30863154
[TBL] [Abstract][Full Text] [Related]
23. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis.
Abdel-Rahman O
Breast Cancer Res Treat; 2017 Jul; 164(1):231-236. PubMed ID: 28417332
[TBL] [Abstract][Full Text] [Related]
27. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
28. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
Yuan SQ; Chen YT; Huang ZP
J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
[TBL] [Abstract][Full Text] [Related]
29. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
30. Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival.
Cates JMM
Ann Surg Oncol; 2017 Dec; 24(13):3880-3887. PubMed ID: 29058143
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
32. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.
Abdel-Rahman O
Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724
[TBL] [Abstract][Full Text] [Related]
33. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
Jiang W; Zhao B; Li Y; Qi D; Wang D
BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
[TBL] [Abstract][Full Text] [Related]
34. External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With N3 Disease.
Shin JY; Yoon JK; Marwaha G
Clin Lung Cancer; 2017 Nov; 18(6):e481-e489. PubMed ID: 28559200
[TBL] [Abstract][Full Text] [Related]
35. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
37. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
Cates JMM
J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
[No Abstract] [Full Text] [Related]
38. Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-analysis.
Wankhede D
Ann Surg Oncol; 2021 Jan; 28(1):142-147. PubMed ID: 32951092
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
[TBL] [Abstract][Full Text] [Related]
40. Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract.
Abdel-Rahman O
Clin Genitourin Cancer; 2018 Aug; 16(4):e859-e865. PubMed ID: 29534942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
